Related Experiment Video
Updated: Dec 9, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Risk of COVID-19 infection after cardiac electrophysiology procedures
Virginia Workman1, James V Freeman1, Edinrin R Obasare1
1Yale School of Medicine, New Haven, Connecticut.
Insights
During the COVID-19 pandemic, cardiac electrophysiology (EP) procedures were safely performed. Patients undergoing EP procedures showed no likely COVID-19 infections, indicating low risk with proper preventive measures.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic led to delays in non-emergent medical procedures, including cardiac electrophysiology (EP).
- Patients expressed concerns regarding potential nosocomial (hospital-acquired) spread of coronavirus.
- Preventive measures were implemented in laboratory areas to mitigate risks.
Purpose of the Study:
- To quantify the risk of developing COVID-19 from in-hospital transmission during EP procedures.
- To assess the effectiveness of preventive measures in reducing COVID-19 transmission in EP labs.
Main Methods:
- Telephone surveys conducted with 124 patients who underwent emergent EP procedures during a COVID-19 surge (March 16–May 15, 2020).
- Assessment of COVID-19 symptoms and testing status at least two weeks post-procedure.
- Review of medical records for outcomes and alternative explanations for symptoms.
Main Results:
- No patients developed documented or suspected COVID-19 infection following their EP procedure.
- Seven patients reported symptoms like chest pain or fever; three tested negative for COVID-19.
- Of the remaining symptomatic patients, two had alternative explanations, and two had transient symptoms not meeting COVID-19 criteria.
Conclusions:
- Despite a high hospital COVID-19 patient census, no likely infections were identified in patients undergoing EP procedures.
- Proper implementation of recommended preventive measures significantly minimizes the risk of nosocomial COVID-19 spread in EP labs.
Background:
During the COVID-19 pandemic, attempts to conserve resources and limit virus spread have resulted in delay of nonemergent procedures across all medical specialties, including cardiac electrophysiology (EP). Many patients have delayed care and continue to express concerns about potential nosocomial spread of coronavirus.
Objective:
To quantify risk of development of COVID-19 owing to in-hospital transmission related to an EP procedure, in the setting of preventive measures instituted in our laboratory areas.
Methods:
We contacted patients by telephone who underwent emergent procedures in the electrophysiology lab during the COVID-19 surge at our hospital (March 16, 2020, to May 15, 2020, reaching daily census 450 COVID-19 patients,) ≥2 weeks after the procedure, to assess for symptoms of and/or testing for COVID-19, and assessed outcomes from medical record review.
Results:
Of the 124 patients undergoing EP procedures in this period, none had developed documented or suspected coronavirus infection. Seven patients described symptoms of chest pain, dyspnea, or fever; 3 were tested for coronavirus and found to be negative. Of the remaining 4, 2 had a more plausible alternative explanation for the symptoms, and 2 had transient symptoms not meeting published criteria for probable COVID-19 infection.
Conclusion:
Despite a high hospital census of COVID-19 patients during the period of hospital stay for an EP procedure, there were no likely COVID-19 infections occurring in follow-up of at least 2 weeks. With proper use of preventive measures as recommended by published guidelines, the risk of nosocomial spread of COVID-19 to patients in the EP lab is low.
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
Myocarditis III: Medical Management

